Gainers
- Agilon Health (NYSE:AGL) stock moved upwards by 17.2% to $4.98 during Monday's after-market session. The market value of their outstanding shares is at $2.0 billion.
- Humana (NYSE:HUM) stock moved upwards by 14.64% to $292.0. The market value of their outstanding shares is at $35.2 billion.
- RenovoRx (NASDAQ:RNXT) stock rose 13.7% to $0.9. The company's market cap stands at $31.9 million.
- Pacira BioSciences (NASDAQ:PCRX) stock moved upwards by 13.48% to $26.0. The market value of their outstanding shares is at $1.2 billion.
- DIH Holding US (NASDAQ:DHAI) stock moved upwards by 9.76% to $0.19. The company's market cap stands at $8.9 million.
- Oragenics (AMEX:OGEN) shares moved upwards by 9.19% to $0.19. The company's market cap stands at $4.0 million.
Losers
- Shattuck Labs (NASDAQ:STTK) stock fell 19.2% to $1.05 during Monday's after-market session. The market value of their outstanding shares is at $50.3 million.
- CVRx (NASDAQ:CVRX) stock fell 14.22% to $9.9. The market value of their outstanding shares is at $257.7 million.
- Entero Therapeutics (NASDAQ:ENTO) shares declined by 13.92% to $0.42. The company's market cap stands at $2.0 million.
- Forte Biosciences (NASDAQ:FBRX) stock decreased by 13.68% to $4.61. The market value of their outstanding shares is at $29.4 million.
- TNF Pharmaceuticals (NASDAQ:TNFA) shares declined by 11.78% to $0.32.
- Bluejay Diagnostics (NASDAQ:BJDX) stock decreased by 10.14% to $6.74. The market value of their outstanding shares is at $3.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BJDXBluejay Diagnostics Inc
$1.583.95%
CVRXCVRx Inc
$7.96-1.36%
DHAIDIH Holding US Inc
$0.19303.21%
ENTOEntero Therapeutics Inc
$4.28-14.4%
FBRXForte Biosciences Inc
$15.00-%
HUMHumana Inc
$247.60-4.83%
OGENOragenics Inc
$1.374.58%
PCRXPacira BioSciences Inc
$25.27-1.94%
RNXTRenovoRx Inc
$1.356.29%
STTKShattuck Labs Inc
$2.28-4.60%
TNFATNF Pharmaceuticals Inc Ordinary Shares
$4.48-13.8%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.